1-5 of 5
Raymond J. Hutchinson, MD
Close
Save search
Sort by
Journal Articles

A Phase I Dose Finding Study of Panobinostat in Children with Hematologic Malignancies: Initial Report of TACL Study T2009-012 in Children with Acute Leukemia

Free
John M Goldberg, MD, Julia Glade-Bender, MD, Maria Luisa Sulis, MD, Rebecca A Gardner, MD, Jessica A. Pollard, MD, Victor Aquino, MD, Naomi J. Winick, MD, Bruce C. Bostrom, MD, Cecilia Fu, MD, Raymond J. Hutchinson, MD, Thomas J. Manley, MD, Rajen Mody, MD MS, Javier Oesterheld, MD, Blythe Thomson, MD, Julie R Park, MD, Jeannette Cassar, Elena Eckroth, CCRC, Richard Sposto, PhD, Yoav H Messinger, MD, Nobuko HiJiya, MD, Paul S Gaynon, MD, Julio C. Barredo, MD
Journal: Blood
Blood (2014) 124 (21): 3705.
https://doi.org/10.1182/blood.V124.21.3705.3705
Published: 2014
Journal Articles

Nelarabine in Combination with Etoposide and Cyclophosphamide Is Active in First Relapse of Childhood T-Acute Lymphocytic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL)

Free
James Whitlock, Luciano dalla Pozza, MBBS, FRACP, John M Goldberg, MD, Lewis B. Silverman, MD, David S. Ziegler, MBBS, FRACP, MD, Andishe Attarbaschi, MD, Patrick Brown, MD, Rebecca A Gardner, MD, Paul S. Gaynon, MD, Raymond J. Hutchinson, MD, Leigh J. Marcus, MD, Yoav H. Messinger, MD, Kirk R. Schultz, MD, Jeannette Vandergiessen, BA, CCRP, Elena Eckroth, CCRC, Franco Locatelli, C Michel Zwaan, Brent L. Wood, MD PhD, Richard Sposto, PhD, Lia Gore, MD
Journal: Blood
Blood (2014) 124 (21): 795.
https://doi.org/10.1182/blood.V124.21.795.795
Published: 2014
Journal Articles

Etanercept Plus Methylprednisolone as Initial Therapy for Acute GVHD.

Free
John E. Levine, MD, MS, Sophie Paczesny, MD, Shin Mineishi, MD, Thomas Braun, PhD, Sung W. Choi, MD, Raymond J. Hutchinson, MD, MS, Dawn Jones, RN, Yasser Khaled, MD, Carrie Kitko, MD, Oleg Krijanovski, MD, Pavan Reddy, MD, Gregory Yanik, MD, James L.M. Ferrara, MD
Journal: Blood
Blood (2007) 110 (11): 39.
https://doi.org/10.1182/blood.V110.11.39.39
Published: 2007
Journal Articles

Changes in TNFR1 Levels in the First Week Post-Myeloablative HSCT Correlate with Severity and Incidence of GVHD and 1y TRM.

Free
John E. Levine, MD, MS, Carrie Kitko, MD, Gregory Yanik, MD, Thomas Braun, PhD, Sophie Paczesny, MD, Shin Mineishi, MD, Oleg Krijanovski, MD, Dawn Jones, RN, Kenneth R. Cooke, MD, Joel Whitfield, Raymond J. Hutchinson, MD, MS, James L.M. Ferrara, MD
Journal: Blood
Blood (2006) 108 (11): 37.
https://doi.org/10.1182/blood.V108.11.37.37
Published: 2006
Journal Articles

Early Marrow Response in CCG-1952: The Prognostic Impact of Poor Day 14 Marrow Response Is Powerful and Only Partially Reversible with Intensified Therapy.

Free
Robert Cho, MD, Linda C. Stork, MD, Paul S. Gaynon, MD, Harland N. Sather, PhD, Mei K. La, MS, Raymond J. Hutchinson, MD
Journal: Blood
Blood (2005) 106 (11): 867.
https://doi.org/10.1182/blood.V106.11.867.867
Published: 2005